{"id":50883,"date":"2014-09-02T22:18:20","date_gmt":"2014-09-02T22:18:20","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=50883"},"modified":"2021-02-03T16:57:59","modified_gmt":"2021-02-03T21:57:59","slug":"occupational-health-safety","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/occupational-health-safety\/","title":{"rendered":"Occupational Health & Safety 2014"},"content":{"rendered":"

… Reilly Published in September 2014 issue of Occupational Health & Safety<\/h3>\n

An article, written by Joe Reilly, connecting drug testing and safety was published this month in Occupational Health & Safety magazine<\/strong>.\u00a0 Drug testing programs<\/strong><\/a> can contribute to the reduction of employee injury- and illness-related costs, including medical care, sick leave, and disability benefit costs.<\/p>\n

Click Here<\/a> for the full article.<\/p>\n\n\n

As an employer, are you taking every step necessary to provide a safe workplace? An employee who works under the influence of drugs or alcohol at work poses a serious safety risk to himself and those around him. Drug testing programs<\/a><\/strong> connect to safety. As an employer, you have both a right and an obligation to maintain a safe and healthy work environment. Enacting a clear drug testing policy to eliminate workplace substance abuse is an important step toward maintaining a safe work environment.
<\/p>\n","protected":false},"excerpt":{"rendered":"

… Reilly Published in September 2014 issue of Occupational Health & Safety An article, written by Joe Reilly, connecting drug testing and safety was published this month in Occupational Health & Safety magazine.\u00a0 Drug testing programs can contribute to the reduction of employee injury- and illness-related costs, including medical care, sick leave, and disability benefit […]<\/p>\n","protected":false},"author":12,"featured_media":51767,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51538,50901,51285,55546,51391,51323","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50883"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=50883"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/51767"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=50883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=50883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=50883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}